Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Virpax Pharmaceuticals ( (VRPX) ) has shared an update.
Virpax Pharmaceuticals has appointed Mr. Jaydriane (Jay) Panis to its Board of Directors following the resignation of Mr. Gary Herman. Mr. Panis, a Certified Financial Planner with over two decades of experience, is expected to bring valuable strategic insights to the company due to his extensive background in financial management and leadership.
More about Virpax Pharmaceuticals
YTD Price Performance: -88.97%
Average Trading Volume: 3,493,312
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.74M
See more data about VRPX stock on TipRanks’ Stock Analysis page.